Browsing by Author "Çamli Pulat Ç."

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    GC-MS Analysis and Apoptotic Effect of Paliurus spina-christi Mill. Leaf and Flower Extracts against Breast Cancer Cells
    (Sakarya University, 2022) Oguz F.; Çamli Pulat Ç.; İlhan S.; Atmaca H.
    In recent years, herbal medicines have become a significant novel source of treatment for various types of cancer, including breast cancer. Various investigations have declared that Paliurus spina-christi Mill. (PSC) shows antioxidant, antifungal, antimicrobial, and antibacterial properties, but its effect on cancer cells is unknown. This study purposed to evaluate the possible anti-cancer effects of the ethanolic extract of the PSC in human MCF-7 and MDA-MB-231 breast cancer cells. The leaf and flower extracts of PSC were prepared in ethanol and volatile compounds were determined by GC-MS analysis. The possible cytotoxic effects of extracts were evaluated via MTT assay. Apoptotic effect was examined using the PI Annexin V Apoptosis Detection Kit. Significant cytotoxic effects were detected after 72 h treatment of ethanolic leaf and flower extracts in MCF-7 cells but not in MDA-MB-231 cells. Both leaf and flower extracts of PSC induced apoptotic cell death in MCF-7 cells. On phytochemical screening, it was shown that the leaf extract of PSC contains pyrrolidine, 2-decenal, 2-undecanal, phytol, oleic acid, oleamide, squalane, vitamin E, and gamma-sitosterol and the flower extract contains pyrrolidine, 2-decenal, 2-undecenal, oleic acid, lupeol, and gamma-sitosterol. These data report that PSC leaf and flower extracts have cytotoxic and apoptotic effects in MCF-7 breast cancer cells. Moreover, this study can be considered an in vitro background for further in vivo cancer experiments. © 2022, Sakarya University. All rights reserved.
  • No Thumbnail Available
    Item
    Design and synthesis of benzimidazole derivatives as apoptosis-inducing agents by targeting Bcl-2 protein
    (Institute for Ionics, 2023) Ilhan S.; Çamli Pulat Ç.; Oguz F.; Bektaş H.; Menteşe E.; Atmaca H.
    Bcl-2, an anti-apoptotic protein, is a well-known and appealing cancer therapy target. Novel series of benzimidazole derivatives were synthesized and tested for their activity as Bcl-2 inhibitors on T98G glioblastoma, PC3 prostate, MCF-7 breast, and H69AR lung cancer cells. MTT assay was used to evaluate the cytotoxic effect. PI Annexin V Apoptosis Detection Kit was used to detect apoptosis. Expression levels of the Bcl-2 protein were examined by the Western blot analysis and qRT-PCR. All synthesized benzimidazole derivatives exhibited a cytotoxic effect on cancer cells with IC50 values in the range of 25.2–88.2 µg/mL. Among all derivatives, compounds C1 and D1 demonstrated a higher cytotoxic effect on cancer cells with IC50 values < 50 µg/mL, while a lower cytotoxic effect against human embryonic kidney cells with IC50 values of > 100 µg/mL. C1 and D1 caused a significant increase in the percentage of apoptotic cells in all types of cancer cell cells and both Bcl-2 mRNA and protein levels were significantly reduced. These results suggest that the novel benzimidazole derivatives may be candidates for apoptosis-inducing agents in cancer treatment by targeting anti-Bcl-2 proteins in cancer cells. Graphical abstract: [Figure not available: see fulltext.]. © 2022, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
  • No Thumbnail Available
    Item
    Hericium erinaceus Extract Induces Apoptosis via PI3K/AKT and RAS/MAPK Signaling Pathways in Prostate Cancer Cells
    (John Wiley and Sons Inc, 2024) Atmaca H.; Çamli Pulat Ç.; Ilhan S.; Kalyoncu F.
    Prostate cancer (PCa) is increasing globally, surpassing lung cancer in incidence. Despite available treatment options, prostate cancer remains incurable. Hence, novel therapeutic strategies are urgently needed to treat PCa. Hericium erinaceus (HE), a medicinal mushroom, offers diverse therapeutic benefits. We examined HE's effects on PCa cells, preparing an ethanol extract and identifying its volatile compounds through GC-MS. MTT assay assessed cell viability, while specific inhibitors and western blotting explored HE's impact on PI3K/AKT and RAS/MAPK pathways. Flow cytometry and ELISA evaluated apoptosis induction. HE showed concentration- and time-dependent cytotoxicity on PCa cells with minimal effects on normal cells. Mechanistically, HE suppressed PI3K/AKT and RAS/MAPK pathways, reducing phosphorylated protein levels. Moreover, it induced PCa cell apoptosis. These findings suggest HE as a potential therapeutic for prostate cancer, shedding light on its cytotoxic and apoptotic effects for further investigation. © 2024 Wiley-VHCA AG, Zurich, Switzerland.